Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05324566 · ClinicalTrials.gov registry record
Evaluation of ECG Transmission and AI Models Using Apple Watch ECGs and Symptoms Data Collected Using a Mayo iPhone App
A clinical trial of Heart Failure and Health Care Utilization, sponsored by Mayo Clinic.
- Completed
- Registry status
- 4,163
- Enrollment target
- 1
- Study location
NCT05324566 is a study of Heart Failure and Health Care Utilization that has completed, run by Mayo Clinic. The registered enrollment target is 4,163 participants, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (104% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05324566, a study of Heart Failure and Health Care Utilization, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 4,163 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine if the Electrocardiograms (ECGs) and symptoms data obtained from an Apple Watch and transmitted to Mayo Clinic are of sufficient quality to guide a person's care.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,163 participants |
| Start Date | 2021-05-05 |
| Est. Completion | 2024-07-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05324566
The ClinicalTrials.gov registry entry for NCT05324566 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,163 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (104% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT05324566 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05324566 about?
NCT05324566 is a clinical study titled "Evaluation of ECG Transmission and AI Models Using Apple Watch ECGs and Symptoms Data Collected Using a Mayo iPhone App". The purpose of the study is to determine if the Electrocardiograms (ECGs) and symptoms data obtained from an Apple Watch and transmitted to Mayo Clinic are of sufficient quality to guide a person's care.
What is the current status of trial NCT05324566?
This trial is currently completed. The enrollment target is 4,163 participants. The study started on 2021-05-05. Estimated completion is 2024-07-09.
What conditions does trial NCT05324566 study?
This clinical trial studies the following conditions: Heart Failure, Health Care Utilization, Arrhythmias, Cardiac.
Who is sponsoring clinical trial NCT05324566?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05324566 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.